FDA recall Z-0382-2022

Clark Laboratories, Inc. · Class II · device

Product

Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440

Reason for recall

Contamination of the conjugate may cause a pipetting issue which then could lead to an invalid assay

Distribution

OH, UT

Key facts

Status
Terminated
Initiation date
2021-10-11
Report date
2021-12-22
Termination date
2023-03-09
Voluntary/Mandated
Voluntary: Firm initiated
Location
Jamestown, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0382-2022